19 results
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
Pathophysiology of Diabetic ... - Type II DM ... food binges, etc Hyperglycemia ... pathophysiology #comparison #endocrinology ... #diabetes #diabetic
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
Type 2 Diabetes ... -> Start Basal Insulin ... after starting insulin ... relative with DM2 ... Management #algorithm #DM2
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
cells, triggering insulin ... : Weight gain, Hypoglycemia ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
Pathogenesis and Pathophysiology of Diabetic Ketoacidosis (DKA)

DKA is a result of an absolute or relative insulin
Pathophysiology of Diabetic ... depletion and hyperglycemia ... abnormalities, including hyperglycemia ... Pathophysiology #Diabetic ... #Endocrinology
Diabetes Morning Hyperglycemia - Dawn Phenomenon vs Somogyi Effect 

When patients FBG's are elevated each morning
Diabetes Morning ... growth hormones and insulin ... adjust and release insulin ... their evening insulin ... Diagnosis #Management #Endocrinology
INSULIN CONVERSION

Total daily dose of insulin (TDD) =
INSULIN CONVERSION ... & most type 2 DM ... or at risk for hypoglycemia ... #diabetes #hyperglycemia ... #dm2 #basalinsulin
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Oral Hypoglycemics ... in Diabetes Management ... 1 INSULIN SENSITIZER ... AmyChung #Oral #Hypoglycemics ... #pharmacology #DM2
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table Insulin ... EricsMedicalLectures/featured #diabetes ... comparison #management #endocrinology ... #dm2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... in Type 1 Diabetes ... monitors in Type 1 Diabetes ... #Mellitus #DM2 ... comparison #table #endocrinology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
• Increases insulin-mediated ... Does not cause hypoglycemia ... mL/minute/1.73 m2 ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology